Control of mammary stem cell function by steroid hormone signalling

Marie-Liesse Labat, François Vaillant, Julie M. Sheridan, Bhupinder Pal, Di Wu, Evan R. Simpson, Hisataka Yasuda, Gordon K. Smyth, T. John Martin, Geoffrey J. Lindeman, Jane E. Visvader

Research output: Contribution to journalArticle

472 Citations (Scopus)

Abstract

The ovarian hormones oestrogen and progesterone profoundly influence breast cancer risk, underpinning the benefit of endocrine therapies in the treatment of breast cancer. Modulation of their effects through ovarian ablation or chemoprevention strategies also significantly decreases breast cancer incidence. Conversely, there is an increased risk of breast cancer associated with pregnancy in the short term. The cellular mechanisms underlying these observations, however, are poorly defined. Here we demonstrate that mouse mammary stem cells (MaSCs) are highly responsive to steroid hormone signalling, despite lacking the oestrogen and progesterone receptors. Ovariectomy markedly diminished MaSC number and outgrowth potential in vivo, whereas MaSC activity increased in mice treated with oestrogen plus progesterone. Notably, even three weeks of treatment with the aromatase inhibitor letrozole was sufficient to reduce the MaSC pool. In contrast, pregnancy led to a transient 11-fold increase in MaSC numbers, probably mediated through paracrine signalling from RANK ligand. The augmented MaSC pool indicates a cellular basis for the short-term increase in breast cancer incidence that accompanies pregnancy. These findings further indicate that breast cancer chemoprevention may be achieved, in part, through suppression of MaSC function.

Original languageEnglish (US)
Pages (from-to)798-802
Number of pages5
JournalNature
Volume465
Issue number7299
DOIs
StatePublished - Jun 10 2010
Externally publishedYes

Fingerprint

Breast
Stem Cells
Steroids
Hormones
Breast Neoplasms
letrozole
Chemoprevention
Pregnancy
Progesterone
Estrogens
Cell Count
Paracrine Communication
RANK Ligand
Aromatase Inhibitors
Incidence
Ovariectomy
Progesterone Receptors
Estrogen Receptors
Therapeutics

ASJC Scopus subject areas

  • General

Cite this

Labat, M-L., Vaillant, F., Sheridan, J. M., Pal, B., Wu, D., Simpson, E. R., ... Visvader, J. E. (2010). Control of mammary stem cell function by steroid hormone signalling. Nature, 465(7299), 798-802. https://doi.org/10.1038/nature09027

Control of mammary stem cell function by steroid hormone signalling. / Labat, Marie-Liesse; Vaillant, François; Sheridan, Julie M.; Pal, Bhupinder; Wu, Di; Simpson, Evan R.; Yasuda, Hisataka; Smyth, Gordon K.; Martin, T. John; Lindeman, Geoffrey J.; Visvader, Jane E.

In: Nature, Vol. 465, No. 7299, 10.06.2010, p. 798-802.

Research output: Contribution to journalArticle

Labat, M-L, Vaillant, F, Sheridan, JM, Pal, B, Wu, D, Simpson, ER, Yasuda, H, Smyth, GK, Martin, TJ, Lindeman, GJ & Visvader, JE 2010, 'Control of mammary stem cell function by steroid hormone signalling', Nature, vol. 465, no. 7299, pp. 798-802. https://doi.org/10.1038/nature09027
Labat M-L, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER et al. Control of mammary stem cell function by steroid hormone signalling. Nature. 2010 Jun 10;465(7299):798-802. https://doi.org/10.1038/nature09027
Labat, Marie-Liesse ; Vaillant, François ; Sheridan, Julie M. ; Pal, Bhupinder ; Wu, Di ; Simpson, Evan R. ; Yasuda, Hisataka ; Smyth, Gordon K. ; Martin, T. John ; Lindeman, Geoffrey J. ; Visvader, Jane E. / Control of mammary stem cell function by steroid hormone signalling. In: Nature. 2010 ; Vol. 465, No. 7299. pp. 798-802.
@article{d78cf2c5ee1a4f5f84c30b5519f96bb1,
title = "Control of mammary stem cell function by steroid hormone signalling",
abstract = "The ovarian hormones oestrogen and progesterone profoundly influence breast cancer risk, underpinning the benefit of endocrine therapies in the treatment of breast cancer. Modulation of their effects through ovarian ablation or chemoprevention strategies also significantly decreases breast cancer incidence. Conversely, there is an increased risk of breast cancer associated with pregnancy in the short term. The cellular mechanisms underlying these observations, however, are poorly defined. Here we demonstrate that mouse mammary stem cells (MaSCs) are highly responsive to steroid hormone signalling, despite lacking the oestrogen and progesterone receptors. Ovariectomy markedly diminished MaSC number and outgrowth potential in vivo, whereas MaSC activity increased in mice treated with oestrogen plus progesterone. Notably, even three weeks of treatment with the aromatase inhibitor letrozole was sufficient to reduce the MaSC pool. In contrast, pregnancy led to a transient 11-fold increase in MaSC numbers, probably mediated through paracrine signalling from RANK ligand. The augmented MaSC pool indicates a cellular basis for the short-term increase in breast cancer incidence that accompanies pregnancy. These findings further indicate that breast cancer chemoprevention may be achieved, in part, through suppression of MaSC function.",
author = "Marie-Liesse Labat and Fran{\cc}ois Vaillant and Sheridan, {Julie M.} and Bhupinder Pal and Di Wu and Simpson, {Evan R.} and Hisataka Yasuda and Smyth, {Gordon K.} and Martin, {T. John} and Lindeman, {Geoffrey J.} and Visvader, {Jane E.}",
year = "2010",
month = "6",
day = "10",
doi = "10.1038/nature09027",
language = "English (US)",
volume = "465",
pages = "798--802",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7299",

}

TY - JOUR

T1 - Control of mammary stem cell function by steroid hormone signalling

AU - Labat, Marie-Liesse

AU - Vaillant, François

AU - Sheridan, Julie M.

AU - Pal, Bhupinder

AU - Wu, Di

AU - Simpson, Evan R.

AU - Yasuda, Hisataka

AU - Smyth, Gordon K.

AU - Martin, T. John

AU - Lindeman, Geoffrey J.

AU - Visvader, Jane E.

PY - 2010/6/10

Y1 - 2010/6/10

N2 - The ovarian hormones oestrogen and progesterone profoundly influence breast cancer risk, underpinning the benefit of endocrine therapies in the treatment of breast cancer. Modulation of their effects through ovarian ablation or chemoprevention strategies also significantly decreases breast cancer incidence. Conversely, there is an increased risk of breast cancer associated with pregnancy in the short term. The cellular mechanisms underlying these observations, however, are poorly defined. Here we demonstrate that mouse mammary stem cells (MaSCs) are highly responsive to steroid hormone signalling, despite lacking the oestrogen and progesterone receptors. Ovariectomy markedly diminished MaSC number and outgrowth potential in vivo, whereas MaSC activity increased in mice treated with oestrogen plus progesterone. Notably, even three weeks of treatment with the aromatase inhibitor letrozole was sufficient to reduce the MaSC pool. In contrast, pregnancy led to a transient 11-fold increase in MaSC numbers, probably mediated through paracrine signalling from RANK ligand. The augmented MaSC pool indicates a cellular basis for the short-term increase in breast cancer incidence that accompanies pregnancy. These findings further indicate that breast cancer chemoprevention may be achieved, in part, through suppression of MaSC function.

AB - The ovarian hormones oestrogen and progesterone profoundly influence breast cancer risk, underpinning the benefit of endocrine therapies in the treatment of breast cancer. Modulation of their effects through ovarian ablation or chemoprevention strategies also significantly decreases breast cancer incidence. Conversely, there is an increased risk of breast cancer associated with pregnancy in the short term. The cellular mechanisms underlying these observations, however, are poorly defined. Here we demonstrate that mouse mammary stem cells (MaSCs) are highly responsive to steroid hormone signalling, despite lacking the oestrogen and progesterone receptors. Ovariectomy markedly diminished MaSC number and outgrowth potential in vivo, whereas MaSC activity increased in mice treated with oestrogen plus progesterone. Notably, even three weeks of treatment with the aromatase inhibitor letrozole was sufficient to reduce the MaSC pool. In contrast, pregnancy led to a transient 11-fold increase in MaSC numbers, probably mediated through paracrine signalling from RANK ligand. The augmented MaSC pool indicates a cellular basis for the short-term increase in breast cancer incidence that accompanies pregnancy. These findings further indicate that breast cancer chemoprevention may be achieved, in part, through suppression of MaSC function.

UR - http://www.scopus.com/inward/record.url?scp=77953384898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953384898&partnerID=8YFLogxK

U2 - 10.1038/nature09027

DO - 10.1038/nature09027

M3 - Article

C2 - 20383121

AN - SCOPUS:77953384898

VL - 465

SP - 798

EP - 802

JO - Nature

JF - Nature

SN - 0028-0836

IS - 7299

ER -